🟢 Painreform is trading 7.09% up in pre-market — no confirmed company-specific catalyst identified

Painreform is trading 7.09% up at $1.03 after closing at $0.96 on August 28, 2026, with no confirmed company-specific catalyst identified.

• No confirmed company-specific announcement, earnings release, or regulatory catalyst dated August 31, 2026 was identified.
• Earnings-date listings are inconsistent, and available press-release feeds provide no confirmed new announcement.
• Broader markets are modestly lower, so global sentiment does not explain the gain.